These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2969678)

  • 41. Cilazapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiovascular disease.
    Deget F; Brogden RN
    Drugs; 1991 May; 41(5):799-820. PubMed ID: 1712710
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of chronic heart failure on the responsiveness to angiotensin I and to angiotensin converting enzyme inhibition with cilazapril in rats.
    Clozel JP
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):167S-174S. PubMed ID: 2527530
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A review of the preclinical cardiovascular pharmacology of cilazapril, a new angiotensin converting enzyme inhibitor.
    Waterfall JF
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):139S-150S. PubMed ID: 2527528
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modulation of the renin-angiotensin-aldosterone system and cough.
    Lacourcière Y; Lefebvre J
    Can J Cardiol; 1995 Aug; 11 Suppl F():33F-39F. PubMed ID: 7664216
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antihypertensive duration of action of cilazapril in patients with mild to moderate essential hypertension.
    Kobrin I; Güntzel P; Viskoper R; Paran E; Zimlichman R
    Drugs; 1991; 41 Suppl 1():31-6. PubMed ID: 1712270
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The pharmacokinetics and dose proportionality of cilazapril.
    Massarella J; DeFeo T; Lin A; Limjuco R; Brown A
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):199S-204S. PubMed ID: 2527533
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Angiotensin converting enzyme inhibitor cough: lessons from heart-lung transplantation.
    Gabbay E; Small T; Corris PA
    Respirology; 1998 Mar; 3(1):39-40. PubMed ID: 9657658
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A pharmacokinetic study of cilazapril in patients with congestive heart failure.
    Rosenthal E; Francis RJ; Brown AN; Rajaguru S; Williams PE; Steiner J; Curry PV
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):267S-273S. PubMed ID: 2548554
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antihypertensive, enzymatic, and hormonal activity of cilazapril, a new angiotensin-converting enzyme inhibitor in patients with mild to moderate essential hypertension.
    Sánchez RA; Traballi CA; Barclay CA; Gilbert HB; Muscará M; Giannone C; Moledo LI
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):230-4. PubMed ID: 2452319
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cough associated with angiotensin-converting enzyme inhibitors.
    Fuller RW
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():159-61. PubMed ID: 2674439
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The positive association of cough with angiotensin-converting enzyme inhibitors.
    Just PM
    Pharmacotherapy; 1989; 9(2):82-7. PubMed ID: 2657676
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cough with angiotensin converting enzyme inhibitors: how much of a problem?
    Fletcher AE; Palmer AJ; Bulpitt CJ
    J Hypertens Suppl; 1994 Jul; 12(2):S43-7. PubMed ID: 7965265
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antihypertensive effects of nitrendipine and cilazapril alone, and in combination in hypertensive patients with chronic renal failure.
    Kloke HJ; Huysmans FT; Wetzels JF; Sluiter HE; Kleinbloesem CH; Koene RA
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):289S-296S. PubMed ID: 2527541
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bronchial hyperreactivity induced by angiotensin converting enzyme inhibitor.
    Goh TC; Ong YY
    Singapore Med J; 1991 Jun; 32(3):183-4. PubMed ID: 1652161
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Complete spontaneous remission of cough induced by ACE inhibitors during chronic therapy in hypertensive patients.
    Reisin L; Schneeweiss A
    J Hum Hypertens; 1992 Aug; 6(4):333-5. PubMed ID: 1433168
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of ACE inhibitor-induced cough.
    Luque CA; Vazquez Ortiz M
    Pharmacotherapy; 1999 Jul; 19(7):804-10. PubMed ID: 10417028
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of ACE inhibition with cilazapril on splanchnic and systemic haemodynamics in man.
    Gasic S; Heinz G; Kleinbloesem C; Korn A
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):225S-234S. PubMed ID: 2548552
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vascular angiotensin converting enzyme activity in spontaneously hypertensive rats and its inhibition with cilazapril.
    Nakamura Y; Nakamura K; Matsukura T; Nakamura K
    J Hypertens; 1988 Feb; 6(2):105-10. PubMed ID: 2832472
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The combined cough frequency/severity scoring: a new approach to cough evaluation in clinical settings.
    Fisman EZ; Shapira I; Motro M; Pines A; Tenenbaum A
    J Med; 2001; 32(3-4):181-7. PubMed ID: 11563816
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A secondary effect of converting enzyme inhibitors: cough].
    Ollivier JP; Ducrocq MB; Droniou J
    Presse Med; 1987 May; 16(16):759-61. PubMed ID: 3035534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.